28 January 2016
A new major collaborative project is set to transform the UK pharmaceutical industry by enabling the manufacturing processes of the innovative medicines of the future to be designed digitally.
The STFC Hartree Centre is a partner in the £20.4m ADDoPT (Advanced Digital Design of Pharmaceutical Therapeutics) project, which involves major pharmaceutical companies, Pfizer, GSK, AstraZeneca and Bristol-Myers Squibb.
A four-year collaboration between government, industry and academia, the project addresses a key challenge for the pharmaceuticals industry; getting new innovative medicines to market in the quickest and most cost-effective way possible to ensure access for patients. It will achieve this by developing advanced digital design techniques that that eliminate non-viable drug candidate formulations as early as possible, streamlining design, development and manufacturing processes.
Part of the Science and Technology Facilities Council, and located at Sci-Tech Daresbury in Cheshire, the Hartree Centre’s world leading supercomputing facilities and expertise in big data analytics and computational chemistry will be applied to case studies, provided by the industrial pharmaceutical project partners, to achieve better design and predictive processes for innovative medicines.
Hartree Centre Business Development Manager for Life Sciences, Dr Adrian Toland, said: “The medicines industry is a major component of UK manufacturing sector with a turnover in excess of £31bn. The industry’s sustainability and future growth will be enhanced by responding to drivers such as the increasing demand for personalised medicines.
“We are extremely excited to be working with our major industrial project partners, as they seek to make innovative and more sophisticated medicines available to patients quicker and more cost effectively. Big data is an essential ingredient in the design and development of our society’s next generation of medicines, taking time and money out of the innovation process. The Hartree Centre’s world leading facilities and skills in data analytics and modelling are pivotal to the success of this project, which will secure the UK’s position at the forefront of new drug development.”
Adrian Toland and Christelle Gendrin from the STFC Hartree Centre explain how the ADDoPT (Advanced Digital Design of Pharmaceutical Therapeutics) project is aiming to address key challenges for the pharmaceutical industry, see video below.
ADDoPT | Big data analytics to transform UK pharmaceutical product development
STFC Press Officer
Tel: 01925 603232 / 07919 548012
Any companies wanting to engage with the work of the Hartree Centre please contact:
Dr Adrian Toland
Business Development Manager, Hartree Centre
Tel: 01925 603241 / 07920275643
Part of the STFC Daresbury Laboratory, and located within the Sci-Tech Daresbury science and innovation campus, the Hartree Centre is driving growth and innovation between science and industry using intense computing.
Every day, the Hartree Centre collaborates with industrial clients and research partners on projects that create insights and value using high performance computing, Big Data analytics, simulation and modelling. By combining one of the most powerful supercomputers in the world dedicated to industrial engagement with access to data scientists, engineers and software specialists, the Centre is enabling organisations of all sizes to produce better outcomes, products and services more quickly and cost-effectively than they can through conventional R&D workflows.
Underpinned by nearly £170m of Government funding, the Hartree Centre is enabling academics and industry within the UK and internationally to solve research challenges, establish competitive advantage and stimulate economic growth.
In partnerships, the Hartree Centre is also developing the next generation of supercomputing architectures and software, combining existing best practice with innovation to deliver faster, more energy sustainable solutions capable of meeting the challenges of data intensive computing.
Last updated: 17 September 2018